ICD-10-CM Billable Code

C69.52

Malignant neoplasm of left lacrimal gland and duct

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of the left lacrimal gland and duct is a rare type of cancer that affects the tear-producing gland located in the corner of the eye, on the left side. This cancer originates from abnormal cell growth in the lacrimal gland or its duct, potentially disrupting normal tear production and eye health. Early detection and treatment are crucial for better outcomes, although diagnosis can be challenging due to the disease's rarity.

Causes & Symptoms

Clinical Causes: T h e e x a c t c a u s e o f m a l i g n a n t n e o p l a s m o f t h e l a c r i m a l g l a n d a n d d u c t r e m a i n s u n k n o w n . H o w e v e r , s e v e r a l f a c t o r s m a y c o n t r i b u t e t o t h e d e v e l o p m e n t o f l a c r i m a l g l a n d t u m o r s , i n c l u d i n g : - G e n e t i c p r e d i s p o s i t i o n s o r i n h e r i t e d m u t a t i o n s - E x p o s u r e t o r a d i a t i o n o r c e r t a i n c h e m i c a l s - C h r o n i c i n f l a m m a t i o n o r p r e v i o u s e y e i n j u r i e s - R a r e l y , i t m a y b e a s s o c i a t e d w i t h s y s t e m i c c a n c e r s o r m e t a s t a t i c d i s e a s e I t ’ s i m p o r t a n t t o n o t e t h a t t h e s e f a c t o r s d o n o t d i r e c t l y c a u s e t h e c a n c e r b u t m a y i n c r e a s e t h e r i s k .

Key Symptoms: S y m p t o m s a s s o c i a t e d w i t h m a l i g n a n c y i n t h e l a c r i m a l g l a n d a n d d u c t c a n v a r y b u t o f t e n i n c l u d e : - A n o t i c e a b l e l u m p o r s w e l l i n g i n t h e u p p e r e y e l i d o r a r o u n d t h e e y e - P e r s i s t e n t r e d n e s s o r i n f l a m m a t i o n - D e c r e a s e d o r a l t e r e d v i s i o n - P a i n o r d i s c o m f o r t a r o u n d t h e a f f e c t e d e y e - C h a n g e s i n e y e m o v e m e n t s - D i p l o p i a ( d o u b l e v i s i o n ) - T e a r i n g o r i n c r e a s e d t e a r p r o d u c t i o n E a r l y s y m p t o m s m i g h t b e m i s t a k e n f o r b e n i g n e y e c o n d i t i o n s , m a k i n g t i m e l y d i a g n o s i s e s s e n t i a l .

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves an array of examinations and tests, such as: - Comprehensive eye examination to assess visual acuity, eye movements, and physical abnormalities - Imaging studies like MRI or CT scans to evaluate the extent of the tumor - Biopsy procedures to obtain tissue samples for histopathological analysis - Additional tests to rule out metastatic disease if suspected Early diagnosis relies on a high index of suspicion, especially when symptoms persist or worsen.

Treatment Protocols: Treatment options depend on the size, location, stage of the tumor, and overall health of the patient. Common approaches include: - Surgical removal of the tumor or affected gland - Radiation therapy to target residual cancer cells - Chemotherapy or targeted therapy in cases of advanced or metastatic disease - Supportive therapies to manage symptoms and preserve vision Multidisciplinary care involving ophthalmologists, oncologists, and radiologists is essential for optimal management. Due to the rarity of this condition, treatment plans are often tailored to individual cases and based on the latest medical research.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C69.52 a billable ICD-10 code?
Yes, C69.52 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C69.52?
Clinical documentation must specify the nature of Malignant neoplasm of left lacrimal gland and duct and any associated comorbidities for accurate reporting.

Cite this Clinical Reference